oesophageal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 18 at the time of signing informed consent. 2. Histologically proven adenocarcinoma, squamous cell carcinoma or mixed type of the oesophagus or gastro-oesophageal junction. 3. Indication for definitive or neoadjuvant CRT, with chemotherapy that consists of weekly carboplatin/paclitaxel. 4. Written, informed consent. 5. Ability to comply with all protocol required actions (at home measurements are done individually by the participant him- or herself).
Exclusion criteria
Exclusion criteria: 1. Altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent or the carrying out of the measurements at home.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At least 80% of participants complete at least 80% of predefined at home measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| n.a. | — |
Countries
Netherlands
Contacts
Universitair Medisch Centrum Groningen